RxDoctor Payments Data

Emily Polus

Psychiatric/Mental Health · Adrian, MINPI 1083120091

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 27.5% of the total. 2025 is the largest year on record at $1,154, 3.5 times the $328 reported in 2022.

$1,989in general payments, 2019–2025

Across 116 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$547
  • AbbVie$501
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$209
  • Alkermes, Inc.$102
  • Supernus Pharmaceuticals, Inc.$98
  • Neurocrine Biosciences, Inc.$93
  • plus $439 from 10 others

What the payments were for

  • Food & beverage$1,989100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,989 in reported general payments places this provider in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan →

Other psychiatric/mental health in Adrian

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →